What is Vertex Pharmaceuticals's change in AR?

Vertex Pharmaceuticals (VRTX) reported change in AR of -$39.8M in Q1 2026.

How has Vertex Pharmaceuticals's change in AR changed year-over-year?

Vertex Pharmaceuticals's change in AR decreased by 123.5% year-over-year, from $169.6M to -$39.8M.

What is the long-term trend for Vertex Pharmaceuticals's change in AR?

Over 2 years (2022 to 2025), Vertex Pharmaceuticals's change in AR has grown at a -3.0% compound annual growth rate (CAGR), from $368.8M to $347.3M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Vertex Pharmaceuticals VRTX Change in AR

Change in AR at other companies

Lexicon PharmaceuticalsLXRX

$9.4M+1,016%

Travere Therapeutics, Inc.TVTX

$7.23M+0.3%

Agios PharmaceuticalsAGIO

$5.56M+826%

AbbVieABBV

-$87M-106%

Prime MedicinePRME

$0-100%

Other financials

Income statement

See full

Revenue$3.0B+7.8%

Gross profit$2.6B+7.8%

Operating income$1.1B+80.6%

Net income$1.0B+59.6%

EPS (diluted)$4.02+61.4%

Balance sheet

See full

Cash & equivalents$5.5B+17.5%

Total debt$2.0B+20.5%

Total equity$19.4B+17.4%

Total assets$26.5B+15.8%

Cash flow

See full

Operating cash flow$1.4B+74.4%

CapEx$133.4M+228%

Free cash flow$1.3B+66.4%

Valuation

See full

Market cap$126.07B+17.7%

Enterprise value$122.55B+18.2%

P/E29.1×—

P/S10.3×+0.9×

Profitability

See full

Gross margin86.2%+0.2pp

Operating margin38.3%—

Net margin35.5%—

FCF margin30.4%+20.2pp

Returns & leverage

See full

Return on equity24.2%—

Debt / equity0.1×0.0×

Current ratio3×+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vertex Pharmaceuticals's change in AR?: Vertex Pharmaceuticals (VRTX) reported change in AR of -$39.8M in Q1 2026.
How has Vertex Pharmaceuticals's change in AR changed year-over-year?: Vertex Pharmaceuticals's change in AR decreased by 123.5% year-over-year, from $169.6M to -$39.8M.
What is the long-term trend for Vertex Pharmaceuticals's change in AR?: Over 2 years (2022 to 2025), Vertex Pharmaceuticals's change in AR has grown at a -3.0% compound annual growth rate (CAGR), from $368.8M to $347.3M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.